Identifying the Barriers of Clinical Trial Access after CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma

被引：0
|
作者：
Kim, Kunhwa [1 ]
Ayers, Amy [2 ]
Ahmed, Sairah [2 ]
Claret, Linda [2 ]
Strati, Paolo [2 ]
Nair, Ranjit [2 ]
Nze, Chijioke [2 ]
Ramdial, Jeremy [3 ]
Torres, Janet [3 ]
Shpall, Elizabeth J. [3 ]
Fayad, Luis E. [4 ]
Nastoupil, Loretta [2 ]
Westin, Jason R. [2 ]
Flowers, Christopher R. [2 ]
Neelapu, Sattva S. [2 ]
Chihara, Dai [2 ]
机构：
[1] Univ Texas MD Anderson, Div Canc Med, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr Houston, Dept Lymphoma & Myeloma, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr Houston, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-211023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5121 / 5122
页数：2
相关论文
共 50 条
  • [31] CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview
    Mohamad Mohty
    Remy Dulery
    Jordan Gauthier
    Florent Malard
    Eolia Brissot
    Mahmoud Aljurf
    Ali Bazarbachi
    Christian Chabanon
    Mohamed A. Kharfan-Dabaja
    Bipin N. Savani
    He Huang
    Saad S. Kenderian
    Miguel-Angel Perales
    Ibrahim Yakoub-Agha
    Arnon Nagler
    Bone Marrow Transplantation, 2020, 55 : 1525 - 1532
  • [32] Hematopoietic recovery and immune reconstitution after axi-cel CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma.
    Strati, Paolo
    Adkins, Sherry
    Nastoupil, Loretta J.
    Westin, Jason
    Hagemeister, Fredrick B.
    Fowler, Nathan Hale
    Lee, Hun Ju
    Fayad, Luis
    Samaniego, Felipe
    Ahmed, Sairah
    Varma, Ankur
    Arafat, Sara
    Johncy, Swapna
    Kebriaei, Partow
    Mulanovich, Victor
    Ariza-Heredia, Ella
    Neelapu, Sattva Swarup
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy
    Yagi, Yu
    Kanemasa, Yusuke
    Sasaki, Yuki
    Goto, Sotaro
    Yamamura, Yasuhiko
    Masuda, Yusuke
    Fujita, Kumiko
    Ishimine, Kento
    Hayashi, Yudai
    Mino, Mano
    Ohigashi, An
    Morita, Yuka
    Tamura, Taichi
    Nakamura, Shohei
    Okuya, Toshihiro
    Matsuda, Shinichiro
    Shimizuguchi, Takuya
    Shingai, Naoki
    Toya, Takashi
    Shimizu, Hiroaki
    Najima, Yuho
    Kobayashi, Takeshi
    Haraguchi, Kyoko
    Doki, Noriko
    Okuyama, Yoshiki
    Shimoyama, Tatsu
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2024, 64 (02) : 107 - 118
  • [34] Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
    Harrysson, Sara
    Eloranta, Sandra
    Ekberg, Sara
    Enblad, Gunilla
    Andersson, Per-Ola
    Sonnevi, Kristina
    Ljungqvist, Maria
    Sander, Birgitta
    Jerkeman, Mats
    Smedby, Karin E.
    LEUKEMIA & LYMPHOMA, 2024, 65 (04) : 534 - 537
  • [35] Allogeneic Transplant As a Curative Option for Relapsed/Refractory Large B-Cell Lymphoma in the Era of CAR T-Cell Therapy: A Monocentric Retrospective Study
    Roche, Pauline
    Brisou, Gabriel
    Furst, Sabine
    Noel, Robin
    De Oca, Catalina Montes
    Collignon, Aude
    Inchiappa, Luca
    De Colella, Jean Marc Schiano
    Rossi, Isabelle Brenot
    Reichert, Thibaut
    Thevenet, Sophie
    Mfarrej, Bechara
    Calmels, Boris
    Blaise, Didier
    Chabannon, Christian
    Devillier, Raynier
    BLOOD, 2022, 140 : 7740 - 7741
  • [36] Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients With Relapsed or Refractory Large B-Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 15 - 17
  • [37] Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma
    Sano, Dahlia
    Nastoupil, Loretta J.
    Fowler, Nathan H.
    Fayad, Luis
    Hagemeister, F. B.
    Lee, Hun Ju
    Samaniego, Felipe
    Wang, Michael
    Rodriguez, Maria Alma
    Iyer, Swaminathan P.
    Parmar, Simrit
    Steiner, Raphael
    Nair, Ranjit
    Adkins, Sherry
    Arafat, Sara
    Rao, Ahalya
    Vallejo, Liliana
    Hawkins, Misha
    Chen, Yiming
    Westin, Jason R.
    Neelapu, Sattva S.
    BLOOD, 2018, 132
  • [38] Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?
    Struessmann, Tim
    Marks, Reinhard
    Waesch, Ralph
    CANCERS, 2024, 16 (11)
  • [39] CAR T-cell therapy in large B cell lymphoma
    Boardman, Alexander P.
    Salles, Gilles
    HEMATOLOGICAL ONCOLOGY, 2023, 41 : 112 - 118
  • [40] Update on CAR T-Cell Therapies for Relapsed/Refractory B-Cell Lymphomas
    Schuster, Stephen J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 622 - 624
12345